Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

2 mins

Greatest Hits of 2024

touchHAEMATOLOGY
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 17th 2024

As 2024 draws to a close, we’re celebrating a great year of content.

From insightful expert Q&As and news articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the haematology community with high-quality, easily accessible content.

Here are just a few of our standout moments from the past year.


Most watched video:

Phase III APPLY-PNH and APPOINT-PNH trials investigate iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria, 48-week data: Phillip Scheinberg, ASH 2023

Dr Phillip Scheinberg discusses results from the phase III APPLY-PNH and APPOINT-PNH trials investigating iptacopan in patients with paroxysmal nocturnal haemoglobinuria, and how they impact PNH treatment strategies in the future.


Most listened to podcast:

Laying the groundwork for medical breakthroughs: The MPN-RC blueprint

John Mascarenhas, MD, joins us to discuss the Myeloproliferative Neoplasms Research Consortium (MPN-RC), an international group dedicated to advancing research and developing innovative treatment strategies for myeloproliferative neoplasms (MPNs

 


Most viewed news story:

red blood cellsISTH unveils new guidelines for haemophilia treatment

Editorial Board member Leonid Battastin shares his thoughts on the evolving role of AI in neurology.

 


Stay informed in 2025 – sign up for our newsletter and get the latest content delivered directly to your inbox.


 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup